08:50 - 10:50 Session 1
General Neuroimmunology "New" Neuroimmunological Diseases
Chairpersons: Joab Chapman, Alexandros Papadimitriou
8:50 - 9:10 Neuroimmunology of Alzheimer's Disease
Joab Chapman (Israel)
9:10 - 9:30 Stroke Immunology and Immunotherapy
Theodoros Karapanayiotides (Greece)
9:30 - 9:50 Autoimmunity in Neurodegenerative Diseases
Georgia Xiromerisiou (Greece)
9:50 - 10:10 Behcet disease and other rare types of CNS demyelinating disease
Ayse Altintas (Turkey)
10:10 - 10:30 Systemic and overlapping autoimmune syndromes with neurological presentation and their management
Rana Karabudak (Turkey)
10:30 - 10:50 Immune intervention in PRION disease animal model
Theodoros Sklaviadis (Greece)
10:50-11:20 Coffee break and Poster Session 1
11:20 - 13:00 Session 2
Chairpersons: Konstantinos Michaelides, Marios Pantzaris
11:20 - 11:40 Axoglial adhesion complexes in health and demyelinating pathologies
Domna Karagogeos (Greece)
11:40 - 12:00 An overview of autoimmune encephalitis and its management
Dimitrios Kitsos (Greece)
12:00 - 12:20 Neurophysiology and neuronal connectivity in neuroimmune diseases
Vasilios Kimiskidis (Greece)
12:20 - 12:40 Paraneoplastic neurological syndromes: pathophysiology, clinical and serological accompaniments
Anastasia Zekeridou (Greece)
12:40 - 13:00 Genetics of MS
George Hadjigeorgiou (Greece)
13:00 - 14:00 Lunch break and Poster Session 2
14:00 - 15:45 Session 3
Stem cells in Neuroimmunology: What is their place? What have we learned in the last decade?
Chairpersons: Mark Freedman and Dimitrios Karussis
14:00 - 14:20 Adult Stem Cells in MS
Nicole Kerlero de Rosbo (Italy)
14:20 - 14:40 Mesenchymal stem cells in ALS and MS: update of the Hadassah clinical trials
Dimitrios Karussis (Israel)
14:40 - 15:00 Modified and neutralised mesenchymal stem cells
Ibrahim Kassis (Israel)
15:00 - 15:20 Hematopoietic stem cells for the treatment of Multiple Sclerosis: The Canadian Experience
Mark Freedman (Canada)
15:20 - 15:45 Comments and discussion on the future of stem cells in neuroimmune and neurodegenerative diseases
Mark Freedman (Canada), Dimitrios Karussis (Israel)
15:45 - 17:00 Session 4
Invited lecture and selected short presentations
Chairpersons: Nathan Karin, Sygkliti - Henrietta Pelidou
15:45 - 16:00 CCR8+FOX3+ regulatory T cells as master drivers of immune regulation at the CNS
Nathan Karin (Israel)
16:00 - 16:10 Rituximab in Myasthenia Gravis
Vasiliki Zouvelou (Greece)
16:10 - 16:20 MG and systemic sarcoidosis
Konstantinos Natsis (Greece)
16:20 - 16:30 CIDP therapy with Rituximab
Thomai Stardeli (Greece)
16:30 - 16:40 Infections besides PML, with monoclonal antibodies
Ioannis Nikolaidis (Greece)
16:40 - 16:50 Therapy with anti-BMP-2/4 ameliorate relapsing experimental autoimmune encephalitis via oligodendrogenesis and without immunosuppressive mechanism
Karin Fainberg, Maya Golan, Arnon Karni, Moshe Benhamou (Israel)
16:50 - 17:00 Anti-MOG encephalitis
Aggeliki-Styliani Sintila (Greece)
17:00 - 17:30 Coffee Break
17:30 - 18:30 Satellite Session (sponsored by ROCHE) :
New Perspectives in MS Disease Understanding and Management
The Dark Side of Progression in RMS
Nikolaos Grigoriadis
The Impact of B Cell Targeted Therapy on Progression in MS
Dimitrios Karussis
18:30 - 19:30 Neuroimmunology Battle Israel against Greece
Moderator: Panayiota Petrou